Ofloxacin Ophthalmic Solution USP 0.3% is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers
The facility will manufacture tablets, capsules, and injections for the oncology segment
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
The inspection classification was determined by the agency as Voluntary Action Indicated
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Rocuronium Bromide Injection is a neuromuscular blocking agent
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
The Board of Directors of Caplin Point Laboratories at its meeting have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The company is the Clinical Research Organisation of Caplin Point Laboratories
Subscribe To Our Newsletter & Stay Updated
